Drug Shortage Report for PMS-OLMESARTAN

Last updated on 2020-11-24 History
Report ID 63085
Drug Identification Number 02461315
Brand name PMS-OLMESARTAN
Common or Proper name OLMESARTAN
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) OLMESARTAN MEDOXOMIL
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-12-20
Estimated end date 2020-12-01
Actual end date 2020-11-23
Shortage status Resolved
Updated date 2020-11-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2020-11-24 French Compare
v15 2020-11-24 English Compare
v14 2020-09-18 French Compare
v13 2020-09-18 English Compare
v12 2019-12-24 French Compare
v11 2019-12-24 English Compare
v10 2019-07-31 French Compare
v9 2019-07-31 English Compare
v8 2019-05-09 French Compare
v7 2019-05-09 English Compare
v6 2019-02-26 French Compare
v5 2019-02-26 English Compare
v4 2019-02-08 French Compare
v3 2019-02-08 English Compare
v2 2018-10-03 French Compare
v1 2018-10-03 English Compare

Showing 1 to 16 of 16